Journal Home
Search for

Volume 75, Issue 1, Pages 81-87 (January 2007)


View previous. 14 of 22 View next.

A simple nurse-based prompt increases screening and prevention counseling for diabetes

John M. BoltriaCorresponding Author Informationemail address, Ike Okosunb, Y. Monique Davis-Smitha, J. Paul Sealea, Phil Romana, Brian W. Tobinc

Received 25 April 2006; accepted 4 May 2006. published online 08 June 2006.

Abstract 

Objective

To determine the impact of a simple nurse-based prompt on fasting glucose screening and counseling regarding diet, exercise and weight loss to persons at increased risk for type 2 diabetes.

Research design and methods

Patients at risk for diabetes were recruited from 10 primary care practices. Nurses were trained to score a diabetes risk assessment and prompt providers concerning all high-risk subjects. Both univariate and multivariate logistic regression models were used to determine the association between the nurse prompt and subsequent fasting glucose testing or receiving advice for diet, exercise, or weight loss.

Results

Of 1176 subjects, 597 were recruited from intervention practices and 579 from control practices. In both the univariate and multivariate models, the intervention group was more likely to receive fasting glucose testing and advice for diet, exercise and weight loss. In the multivariate model, patients in the intervention group were more likely to receive fasting glucose testing (odds ratio 9.3, 95% confidence interval 3.6–24.0), dietary advice (6.1, 3.5–10.7), exercise advice (7.4, 4.0–13.9), and weight loss advice (1.9, 1.1–3.7).

Conclusions

A simple nurse-based prompt is an effective tool to increase screening and preventive services for people at risk for type 2 diabetes.

Article Outline

Abstract

1. Introduction

2. Materials and methods

2.1. Practice selection

2.2. Subject selection

2.3. Training

2.4. The prompt

2.5. Data collection

2.6. Statistical analysis

3. Results

4. Discussion

4.1. Limitations

5. Conclusion

Acknowledgment

References

Copyright

1. Introduction 

return to Article Outline

Type 2 diabetes is an increasing problem in the United States. Approximately 17 million Americans have diabetes and an estimated 12 million US citizens have pre-diabetes (impaired fasting glucose or impaired glucose tolerance) [1], [2]. Diabetes increases the risk of many medical disorders including cardiovascular disease, renal failure, amputations, blindness and early death [3], [4], [5]. Numerous successful interventions have been demonstrated to delay or prevent both the onset of diabetes and the complications associated with diabetes using both lifestyle modification and medications [6], [7], [8], [9], [10], [11], [12], [13]. Both the ADA and the American Academy of Clinical Endocrinologists advocate early screening and intervention [14], [15]. Despite these recommendations, recent reports indicate that nearly 5 million Americans have undiagnosed diabetes and nearly half of these persons have levels of hemoglobin A1c in the range associated with diabetes complications [1], [2], [16].

There have been many reports concerning the costs and strategies for screening for diabetes. However the conclusions suggest that routine population screening is too costly, not successful, or not substantial [17], [18], [19], [20], [21]. Efforts to improve diabetes screening and early intervention have had mixed results. In a recent survey in Montana 48% of persons with two diabetes risk factors and 37% of persons with three risk factors had not been screened for diabetes during the past 3 years [22]. Unfortunately, opportunistic rather than population screening based on increased risk for diabetes is the more common method for identifying persons with diabetes [23], [24]. A large population-based screening study using a self-administered risk chart distributed by mail, followed by office-based glucose testing, identified only 19% of persons with undiagnosed diabetes [25].

Although there are a number of reports of community-based screening, there are few published reports of efforts to improve office-based screening and intervention in order to increase preventive counseling in persons at high-risk for diabetes [20], [24], [26]. Fasting glucose (FG) or oral glucose tolerance test (OGTT) are the recommended screening tests for diabetes, however, these are often not used in primary care practice. In a recent office-based HMO study spanning 3 years, only 90 (1%) of 8286 patients 45 years old and older were screened with a fasting glucose and only 11 (0.1%) received an OGTT. Additionally, only 38% of the patients with abnormal results received appropriate follow-up testing and treatment [23].

Prompts have been shown to improve the delivery of preventive services in a number of settings including primary care offices [27], [28], [29]. Based on these findings, we hypothesized that having a nurse score a diabetes risk survey and prompt the physicians for patients at increased risk for diabetes would result in increased screening and preventive counseling for diabetes. The purpose of this study was to assess the impact of a simple nurse-based prompt on screening and intervention rates for persons at increased risk for diabetes in an outpatient setting.

2. Materials and methods 

return to Article Outline

2.1. Practice selection 

All subjects were recruited from 10 practices from the Georgia-Mercer Practice Based Research Network. These 10 outpatient private primary care practices that included both internal medicine and family medicine were randomly assigned to either intervention or control groups. All practices were informed that the purpose of the study was to improve early detection of common chronic diseases including diabetes, hypertension and obesity. All practices were aware that screening rates for chronic diseases were to be measured. None of the practices knew that the intervention was the nurse prompt. They were therefore blinded as to whether they were an intervention or control practice. The Mercer University Institutional Review Board approved this study.

2.2. Subject selection 

Subject recruitment and inclusion/exclusion criteria: at all sites the subjects were recruited in the waiting room by a research assistant who asked each subject to participate in a study on early detection and intervention for chronic diseases. Subjects were also blinded to the fact that this study concerned diabetes screening and intervention. All consenting subjects ≥18 years old participated. Subjects with diabetes, those less than 18 years old, prisoners, and mentally retarded subjects were excluded. Only subjects who had at least one risk factor for diabetes according to the ADA were included in this analysis [30].

2.3. Training 

At the start of the study at each intervention practice, nurses were provided with a 30min instruction session on the ADA high-risk guidelines for diabetes [30]. This included determination of BMI and training to score the risk survey. If the patient had one or more risk factors for diabetes, the nurse was instructed to prompt the doctor by providing the results of the assessment in a conspicuous place on the chart.

2.4. The prompt 

All subjects received a survey that included the American Diabetes Association questions for diabetes risk. This chronic disease survey contained 19 questions, including 10 questions regarding ADA associated risk factors for diabetes as well as 3 questions on symptoms associated with diabetes [30]. At control sites, the research assistant collected the survey, while at intervention sites each subject handed the survey to the nurse, who scored the survey during the vital signs check-in. The nurse determined a BMI and then scored the survey by circling all positive ADA risk questions. BMI charts were posted at all sites where vital signs were checked in each office. If the patient scored positive, i.e. at least one risk factor for diabetes, the nurse placed the completed and scored survey in a conspicuous place on the chart to prompt the physician. In order to make the prompt obvious, orange colored paper was used. In all but one intervention practice, the orange colored risk survey was placed either on the front of the chart or on top of the progress note sheet to prompt the physician. In one practice with an electronic medical record (EMR), the orange survey was placed on the door of the patient's exam room to prompt the doctor. In order to ensure that all high-risk subjects were offered screening after study completion, all high-risk subjects from both the control and intervention groups who had not received diabetes screening were informed of their risk and asked to return to their primary care physician for further screening and counseling.

2.5. Data collection 

At all sites the nurses were observed in order to ascertain the amount of additional time it took to determine a BMI and score the survey. Three months after the study every chart was reviewed. The primary endpoints were documentation of the physician providing plans for diet, exercise and weight loss and evidence of fasting glucose screening for diabetes. Data extraction also included demographic data, past history of vascular disease, and evidence of a notation on the chart that the patient was high-risk for developing diabetes. If plans for diet, exercise, and weight loss were not documented in the chart, they were counted as not performed. Recommending a specific diet, giving a diet handout or referral to a dietician was counted as providing a diet plan. Recommending exercise or any increase in physical activity was counted as providing exercise advice. Weight loss advice was counted only if there was a specific recommendation to lose weight or lower BMI. Finally, evidence of fasting glucose testing was ascertained. If the glucose test result was random or if it was not labeled as fasting, it was not counted as a fasting glucose. A master's level research assistant was trained in chart extraction. For the first 25 charts both the research assistant and the principal investigator independently performed data extraction on the same charts. Retraining was performed to increase concordance to ≥95%. At each of the 10 practices, the principal investigator performed quality control by randomly pulling 10 charts and independently repeating the chart extraction. The data extraction forms were then compared with those from the research assistant. In all cases the concordance with data extraction was ≥95% and no further training was required. Some charts were not available during the initial extraction period. Each practice was repeatedly visited until extraction from all charts was completed. Office visits and fasting glucose results obtained more than 3 months after the intervention were disregarded. Only data included in the charts were included in this analysis. A different research assistant who was blinded to the site (intervention or control) entered all data.

2.6. Statistical analysis 

All data were entered into SPSS version 13.0. Differences between intervention and control groups for continuous variables including age, BMI, and ADA risk score were assessed using independent t-tests. Differences between intervention and control groups for categorical variables including degree of adiposity, gender, race/ethnicity, diet plans, exercise plans, weight loss plans, fasting glucose screening and risk profiles were assessed with Chi-squared tests.

To investigate the effect of the nurse prompt on plans for diet, exercise, and weight control and FG screening, the nurse prompt was used as the dependent variable in the logistic regression analysis. The dependent variable was categorized as 1 and 0, representing nurse prompt and no nurse prompt, respectively. Univariate and multivariate logistic regression models were fitted using each of the independent variables. Statistical adjustments were made for age, BMI, sex, race/ethnicity and ADA risk score in the multivariate regression analyses. The customary p-value of <0.05 and 95% confidence intervals were used to indicate statistical significance.

3. Results 

return to Article Outline

Of the 1438 subjects who were recruited from 10 outpatient primary care practices, 1176 met eligibility criteria. In all practices the nurses took on average less than 20s to determine the BMI and score the prompt.

The basic anthropometric characteristics of eligible subjects are shown in Table 1. A total number of 597 intervention and 579 control subjects were eligible for this investigation. Although there were no significant differences in ADA risk scores, some differences were found between groups. Overall, the intervention group was older than the control group (p<0.001). Compared to the intervention group, the control group was heavier as defined by BMI (p<0.001). There were gender and racial/ethnic differences between intervention and control groups. The proportions of women and Blacks were higher in the control group compared to the intervention group (p<0.001).

Table 1.

Characteristics of studied variables

Intervention groupControl groupp-value
Sample size (n)597579
Age (y)52.9±16.746.5±14.7<0.001
BMI (kg/m2)29.5±6.331.1±6.7<0.001
ADA risk score3.85±1.983.87±1.960.889
Degree of adiposity (%)
Normal22.917.30.001
Overweight35.129.2
Obese42.053.5
Gender (%)
Men35.726.6<0.001
Women64.373.4
Race/ethnicity (%)
White76.249.4<0.001
Black19.947.7
Others3.92.9

ADA, American diabetes association.

Comparative analyses of ADA diabetes risk factors in the intervention and control groups are shown in Table 2. There were significantly more subjects with an age of ≥45 years, a history of vascular disease, and an immediate family member with diabetes in the intervention compared with the control group. The control group had more subjects with BMI ≥25 (kg/m2), and more at risk subjects (defined as non-Whites) compared with the intervention group. There were more females who had babies weighing more than 9lbs in the intervention group compared with the control group.

Table 2.

Diabetes risk factors (in %) of intervention and control groups

Risk factorIntervention groupControl groupp-value
BMI greater than 25 (kg/m2)77.182.70.024
Age ≥45 (years)67.748.0<0.001
At-risk race23.850.6<0.001
HDL<35 (mg/dl) or TG>200 (mg/dl)19.118.30.333
Polycystic ovarian syndromea1.02.10.226
History of hypertension80.577.30.333
History of IFG or IGT0.80.60.663
History of vascular disease13.25.9<0.001
Immediate family with diabetes37.044.60.009
Have had baby weighing greater than 9lbsa17.812.50.036
Have had gestational diabetesa3.14.20.408
History of frequent urination19.816.20.115
History of blurred vision12.911.60.488
History of pain while walking31.832.30.862

IFG, impaired fasting glucose; IGT, impaired glucose tolerance.

a

Values are for women (n=808).

Following the intervention, the percent of intervention versus control subjects with diet, exercise and weight control plans were 28.8 versus 3.8, 23.6 versus 3.8 and 6.4 versus 3.1, respectively (p<0.001). The percent of intervention versus control subjects receiving FG screening was 11.6% versus 1.4% (p<0.001). The impact of the nurse prompt on FG screening, diet plans, exercise plans, and weight loss plans are shown in Table 3. Before adjusting for other independent variables (Model I), the nurse prompt was associated with 10.2, 7.4, 6.8, and 1.5 increased odds of FG screening, diet, exercise, and weight loss plans, respectively. In the multiple logistic regression analyses (Model II), adjusting for age, BMI, gender, race/ethnicity and ADA risk score, the nurse prompt was also associated with 9.3, 6.1, 7.4, and 1.9 increased odds of FG screening, diet, exercise, and weight loss plans, respectively. Adjusting for other covariates, female gender and increased age were also associated with increased odds of FG screening, diet, and exercise plans (p<0.01).

Table 3.

Relationship between simple nurse prompt and odds of receiving fasting glucose screening, diet plan, exercise plan, and weight loss plan

Diet PlanExercise planWeight loss planFG Screening
OR, 95% CIpOR, 95% CIpOR, 95% CIpOR, 95% CIp
Model I: univariate
Prompt7.4, 4.5–12.4<0.0016.8, 5.0–15.6<0.0011.5, 1.0–2.8<0.00110.2, 4.6–22.3<0.001
Model II: multivariate
Prompt6.1, 3.5–10.7<0.0017.4, 4.0–13.9<0.0011.9, 1.1–3.70.0359.3, 3.6–24.0<0.001
Age1.3, 1.1–1.8<0.0011.4, 1.3–1.7<0.0011.2, 1.0–1.40.0921.5, 1.3–1.60.001
BMI1.4, 1.0–1.70.0501.1, 0.9–1.10.2571.2, 1.1–1.30.0141.0, 0.9–1.40.993
Sex2.3, 1.5–3.5<0.0012.3, 1.5–3.5<0.0011.2, 0.6–2.40.5742.0, 1.2–3.30.008
Race0.9, 0.5–1.50.6480.7, 0.4–1.10.1270.4, 0.2–0.80.0161.4, 0.7–2.70.299
Score1.1, 0.9–1.20.7391.0, 0.9–1.10.6630.9, 0.8–1.20.6860.9, 0.8–1.10.342

OR, odds ratio from the logistic regression models; p, p-value; CI, confidence intervals; FG, fasting glucose; sex, female; race, African American; score, ADA risk score.

Data from the chart review also revealed that following the intervention, 70.9% of the subjects in the intervention group had a notation of high-risk for diabetes on their chart whereas only 29.1% of the subjects in the control group had such a notation (p<0.001).

4. Discussion 

return to Article Outline

This study employed a simple office-based intervention which significantly improved office-based management of patients at risk for diabetes at three levels: identification, as evidenced by documentation in the medical record; diagnosis by fasting glucose testing; and provision of advice regarding diet, exercise and weight reduction. The intervention employed three strategies for improving diabetes screening and treatment which have been advocated by the ADA: improving health professional education regarding the standards of diabetes care, using reminders and prompts, and training nurses to use algorithms [14]. Implementation of the intervention required approximately 30min of nurse training and orientation of the physician providers, which was usually accomplished over lunch. Scoring of the prompt and calculations of BMI required minimal additional nursing time (only about 20s per patient). This simple, low cost, office-based intervention shows promise for increasing the identification and treatment of patients with diabetes and prediabetes in primary care settings.

As the prevalence of obesity and diabetes continue to increase in the United States, it is imperative that primary care professionals improve their ability to provide early screening and delivery of services for diabetes prevention in persons at high-risk for diabetes. Early detection and intervention are also needed to decrease the high number of individuals who are already experiencing the complications of diabetes at the time of diagnosis [31], [32], [33], [34], [35]. Implementation of early screening and lifestyle change counseling in primary care settings is challenging because of the time limitations of primary care visits and the many competing demands for screening and prevention counseling [36]. The low cost, time efficient intervention employed in this project was effectively implemented, despite these limitations. Once physician and nurse training have been completed, the cost of ongoing screening is equal to the cost of copy paper and the brief amount of nurse time necessary to score the survey. This makes this intervention easily sustainable for most outpatient practices.

This prompt was also implemented in one practice with an electronic medical record (EMR) without difficulty. The paper prompt was scanned into the chart on the same day and became a permanent part of the electronic record. An automated electronic prompt could prove to be an even more effective tool. Further studies are needed to determine the effectiveness of a prompt embedded in an EMR on diabetes screening and intervention rates. The ADA recommends screening at 3-year intervals in all persons aged ≥45 (particularly those with BMI ≥25) as well as in younger persons who have elevated BMI and another risk factor [14]. Future studies should include chart prompts for periodic re-screening of patients who screen negative. Again, an automated electronic prompt within an EMR seems a simple method for accomplishing this goal.

4.1. Limitations 

First, although this study was blinded to the practices, it was not blinded to the research assistants who recruited the subjects. However, the research assistants were blinded to the primary endpoints. Because this study relied heavily on the nurses at each intervention practice, none of who were members of our research team, we feel that the lack of blinding did not significantly skew the data. Second, chart reviews may not accurately reflect the amount of advice that physicians deliver to patients. For example, they may have delivered advice that was not recorded, leading to underestimation of the amount of diet, exercise and weight loss advice given. Third, this study did not seek to measure change in patient behavior that may have resulted from the physician's advice or from fasting glucose screening. Finally, there were significant differences between the intervention and control groups in age, BMI, gender, and race/ethnicity. However, the ADA risk scores were not significantly different between the two groups and the multivariate model demonstrated that the nurse prompt had the highest odds of increasing diabetes screening and provision of diet, exercise, and weight loss plans (Table 3).

5. Conclusion 

return to Article Outline

In our trial, a simple nurse-based prompt was an effective instrument that significantly increased documentation of diabetes risk, fasting glucose screening, and the delivery of preventive services, including advice to improve diet, increase exercise and lose weight. Further studies are needed to develop more effective office-based tools to increase screening and early intervention for persons at risk for diabetes.

Acknowledgement 

return to Article Outline

The authors wish to thank Monica Cornelius for her help in implementing this study.

References 

return to Article Outline

[1]. [1]Centers for Disease Control, Prevention. Prevalence of diabetes and impaired fasting glucose in adults, United States, 1999–2000. MMWR. 2003;52:833–837.

[2]. [2]Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diab Care. 2003;26:645–649.

[3]. [3]Diabetes Control, Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA. 1996;276:1409–1415. MEDLINE

[4]. [4]The absence of a glycemic threshold for the development of long-term complications: the perspective of the diabetes control, complications, trial. Diabetes. 1996;45:1289–1298. MEDLINE

[5]. [5]The relationship of glycemic exposure (HbA1c) to the risk of development, progression of retinopathy in the diabetes control, complications trial. Diabetes. 1995;44:968–983. MEDLINE

[6]. [6]UK., Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853. Abstract | Full Text | Full-Text PDF (708 KB) | CrossRef

[7]. [7]UK, Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–865. Abstract | Full Text | Full-Text PDF (582 KB) | CrossRef

[8]. [8]UK, Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713.

[9]. [9]UK, Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ. 1998;317:713–720.

[10]. [10]Diabetes Control, Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986. MEDLINE | CrossRef

[11]. [11]Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes prevention program research group: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403. CrossRef

[12]. [12]Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Finnish diabetes prevention study group: prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350. MEDLINE | CrossRef

[13]. [13]Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The da qing IGT and diabetes study. Diab Care. 1997;20:537–544.

[14]. [14]American Diabetes Association. Standards of medical care in diabetes-. Diab Care. 2006;29(Suppl 1):S4–S42.

[15]. [15]American College of Endocrinology. Consensus statement on guidelines for glycemic control [article online]. Endocr Pract. 2002;8:5–11Available from http://www.aace.com/meetings/consensus/dcc/pdf/dccwhitepaper.pdf.

[16]. [16]Boltri JM, Okosun IS, Davis-Smith M, Vogel RL. Hemoglobin A1c levels in diagnosed and undiagnosed Black, Hispanic and white persons with diabetes: results from NHANES 1999-2000. Ethn Dis. 2005;15:562–567.

[17]. [17]Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Narayan KM. Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. Diab Care. 2003;26:2536–2542.

[18]. [18]Johnson SL, Tabaei BP, Herman WH. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the US population 45–74 years of age. Diab Care. 2005;28:307–311.

[19]. [19]Zhang P, Engelgau MM, Valdez R, Cadwell B, Benjamin SM, Narayan KM. Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis. Diab Care. 2005;28:1321–1325.

[20]. [20]Colagiuri S, Hussain Z, Zimmet P, Cameron A, Shaw J. AusDiab: screening for type 2 diabetes and impaired glucose metabolism: the Australian experience. Diab Care. 2004;27:367–371.

[21]. [21]Icks A, Haastert B, Gandjour A, John J, Lowel H, Holle R, et al. KORA study group: cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA survey. Diab Care. 2004;27:2120–2128.

[22]. [22]Harwell TS, Smilie JG, McDowall JM, Helgerson SD, Gohdes D. Diabetes screening practices among individuals aged 45 years and older. Diab Care. 2000;23:125–126.

[23]. [23]Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH. Opportunistic screening for diabetes in routine clinical practice. Diab Care. 2004;27:9–12.

[24]. [24]Edelman D, Edwards LJ, Olsen MK, Dudley TK, Harris AC, Blackwell DK, et al. Screening for diabetes in an outpatient clinic population. J Gen Intern Med. 2002;17:23–28. MEDLINE | CrossRef

[25]. [25]Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia. 2004;47:1566–1573. CrossRef

[26]. [26]Tabaei BP, Burke R, Constance A, Hare J, May-Aldrich G, Parker SA, et al. Community-based screening for diabetes in Michigan. Diab Care. 2003;26:668–670.

[27]. [27]Schmittdiel J, McMenamin SB, Halpin HA, Gillies RR, Bodenheimer T, Shortell SM, et al. The use of patient and physician reminders for preventive services: results from a national study of physician organizations. Prev Med. 2004;39:1000–1006. MEDLINE | CrossRef

[28]. [28]McIsaac WJ, Goel V, To T, Permaul JA, Low DE. Effect on antibiotic prescribing of repeated clinical prompts to use a sore throat score: lessons from a failed community intervention study. J Fam Pract. 2002;51:339–344. MEDLINE

[29]. [29]Bordley WC, Margolis PA, Stuart J, Lannon C, Keyes L. Improving preventive service delivery through office systems. Pediatrics. 2001;108:E41.

[30]. [30]American Diabetes Association. Screening for type 2 diabetes. Diab Care. 2003;26(Suppl 1):S21–S24.

[31]. [31]Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, et al. United Kingdom prospective diabetes study, 30 diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol. 1998;116:297–303. MEDLINE

[32]. [32]Rajala U, Laakso M, Qiao Q, Keinanen-Kiukaanniemi S. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diab Care. 1998;21:1664–1669.

[33]. [33]Ballard DJ, Humphrey LL, Melton LJ, Frohnert PP, Chu PC, O’Fallon WM, et al. Epidemiology of persistent proteinuria in type II diabetes mellitus. population-based study in Rochester, Minnesota. Diabetes. 1988;37:405–412. MEDLINE

[34]. [34]Drivsholm T, de Fine Olivarius N, Nielsen AB, Siersma V. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight. Diabetologia. 2005;48:210–214. CrossRef

[35]. [35]Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diab Care. 2001;24:1522–1527.

[36]. [36]Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention?. Am J Public Health. 2003;93:635–641. MEDLINE | CrossRef

a Department of Family Medicine, Mercer University School of Medicine, Macon, GA, United States

b Institute of Public Health, Georgia State University, Atlanta, United States

c Department of Basic Sciences, Mercer University School of Medicine, Macon, GA, United States

Corresponding Author InformationCorresponding author at: Department of Family Medicine, Mercer University School of Medicine, 3780 Eisenhower Parkway, Macon, GA 31206, United States. Tel.: +1 478 633 5550; fax: +1 478 784 5496.

 This project was supported in part by grants from the Medcen Foundation, Macon Georgia, the US Department of Health and Human Services, Health Resources and Services Administration (HRSA), Grant #5D12HP00159, and National Institutes of Health Grant #1 K07 HL04305-01.

PII: S0168-8227(06)00176-8

doi:10.1016/j.diabres.2006.05.002


View previous. 14 of 22 View next.